• PDG39 CHALLENGE OR OPPORTUNITY? THE EXPANSION OF DRUG VOLUME-BASED PROCUREMENT IN CHINA

    May 1, 2020, 00:00

  • Objective Estimates of Direct-Medical Costs Among Persons Aged 3 to 38 Years With and Without Research-Defined Autism Spectrum Disorder Ascertained During Childhood: A Population-Based Birth-Cohort Study

    May 1, 2020, 00:00

  • Shedding Light on Reimbursement Policies of Companion Diagnostics in European Countries

    May 1, 2020, 00:00

  • PMS86 QUALITY OF LIFE AND WORK PRODUCTIVITY BY PAIN SEVERITY AMONG INDIVIDUALS WITH OSTEOARTHRITIS IN THE UNITED STATES: ANALYSIS OF A CROSS-SECTIONAL SURVEY

    May 1, 2020, 00:00

  • PDG61 TYPES OF ENDPOINTS OF NEW MOLECULAR ENTITIES APPROVED BY THE FDA: THE INCREASING IMPORTANCE OF PATIENT-REPORTED OUTCOMES

    May 1, 2020, 00:00

  • PMS31 ANNUAL HEALTH INSURANCE TREATMENT COST OF INJURIES TO THE ANKLE AND FOOT BASED ON ROUTINELY COLLECTED REAL-WORLD FINANCING DATA

    May 1, 2020, 00:00

  • PIH46 COSTS AND OUTCOMES ASSOCIATED TO POTENTIALLY INAPPROPRIATE DRUG PRESCRIBING DETECTED BY ALGORITHM: PRELIMINARY RESULTS FROM THE MAPT STUDY

    May 1, 2020, 00:00

  • PGI41 SYSTEMATIC LITERATURE REVIEW AND META-ANALYSIS OF HEALTH UTILITIES IN PATIENTS WITH ULCERATIVE COLITIS

    May 1, 2020, 00:00

  • Injury Trauma - Clinical Outcomes

    May 1, 2020, 00:00

  • PCV73 COMPARATIVE EFFICACY AND SAFETY OF NEW ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION AND PERCUTANEOUS CORONARY INTERVENTION: A NETWORK META-ANALYSIS WITH MULTICRITERIA DECISION ANALYSIS

    May 1, 2020, 00:00

  • Infectious Diseases - Health Policy Regulatory

    May 1, 2020, 00:00

  • PIH13 IMPACT OF INCREASED UTILIZATION OF LONG-ACTING REVERSABLE CONTRACEPTIVE METHODS AMONG YOUNG WOMEN ON COST AND UNINTENDED PREGNANCIES (UP) IN THE UNITED STATES (US)

    May 1, 2020, 00:00

  • Diabetes/Endocrine/Metabolic Disorders - Methodological Statistical Research

    May 1, 2020, 00:00

  • A Systematic Review of Economic Evaluations Reporting the Cost-Effectiveness of Spinal Cord Stimulation

    May 1, 2020, 00:00

  • PBI13 TRENDS IN LIST PRICES, NET PRICES, AND DISCOUNTS OF SELF-ADMINISTERED TUMOR NECROSIS FACTOR INHIBITORS

    May 1, 2020, 00:00

  • PMS26 ANNUAL HEALTH INSURANCE TREATMENT COST OF INJURIES TO THE KNEE AND LOWER LEG BASED ON ROUTINELY COLLECTED REAL-WORLD FINANCING DATA

    May 1, 2020, 00:00

  • PMH20 ECONOMIC BURDEN OF ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD): A GLOBAL SYSTEMATIC REVIEW

    May 1, 2020, 00:00

  • Individual's Health - Epidemiology Public Health

    May 1, 2020, 00:00

  • PMU68 ASSESSING THE EFFECT OF THE DIETICIAN PROGRAM FOR MEMBERS WITH CHRONIC DISEASES AT BLUE CROSS BLUE SHIELD OF LOUISIANA

    May 1, 2020, 00:00

  • PMD14 PREVENTION VERSUS TREATMENT OF VENOUS ULCERS IN BRAZILIAN NATIONAL HEALTH SYSTEM: HOW MUCH COULD BE SAVED?

    May 1, 2020, 00:00

  • PMD41 ASSESSING THE CLINICAL EFFECTIVENESS OF POLYSOMNOGRAPHY AND PORTABLE DEVICE (LEVEL III) FOR THE DIAGNOSIS OF SLEEP DISORDER BREATHING: SYSTEMATIC REVIEW META-ANALYSIS

    May 1, 2020, 00:00

  • PMU48 EFFECT OF MOBILE HEALTH INTERVENTIONS ON MATERNAL AND CHILD HEALTH: A SYSTEMATIC REVIEW OF RANDOMIZED CONTROLLED TRIALS

    May 1, 2020, 00:00

  • The EQ-5D-5L Value Set for England: Findings of a Quality Assurance Program

    May 1, 2020, 00:00

  • PMS46 USE OF HEALTHCARE RESOURCES IN A COHORT OF COLOMBIAN PATIENTS TREATED WITH BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS OR TOFACITINIB, 2014–2018

    May 1, 2020, 00:00

  • PDB105 STUDY OF INTERRUPTED TIME SERIES TO DETERMINE THE EFFECT OF POLICY IN PATIENTS WITH T2DM USING SGLT2 IN TWO HEALTH MAINTENANCE ORGANIZATION IN COLOMBIA

    May 1, 2020, 00:00

  • Medical Devices - Real World Data Information Systems

    May 1, 2020, 00:00

  • PIN47 COMPARATIVE BUDGET IMPACT ANALYSIS OF PNEUMOCOCCAL VACCINES IN COLOMBIAN IMMUNIZATION PROGRAM

    May 1, 2020, 00:00

  • PMH21 PROVIDING THE DEPRESSION CARE FOR PEOPLE WITH CANCER PROGRAM TO PROSTATE CANCER PATIENTS IN THE UNITED STATES: A COST-EFFECTIVENESS ANALYSES

    May 1, 2020, 00:00

  • PMS54 EPIDEMIOLOGICAL DISEASE BURDEN OF INJURIES TO THE SHOULDER AND UPPER ARM BASED ON ROUTINELY COLLECTED HEALTH INSURANCE CLAIMS DATA

    May 1, 2020, 00:00

  • PCV54 AGE-SPECIFIC EXAMINATION OF EARLY CEREBROVASCULAR MORTALITY: 1990-2014

    May 1, 2020, 00:00

  • PIH6 PREFERENCES AND WILLINGNESS TO PAY FOR EARLY DIAGNOSIS OF ENDOMETRIOSIS TO REDUCE THE ADVERSE RISK OUTCOMES: A DISCRETE CHOICE EXPERIMENT

    May 1, 2020, 00:00

  • Musculoskeletal Disorders - Health Service Delivery Process of Care

    May 1, 2020, 00:00

  • PMH64 INPATIENT PRESCRIBING PATTERNS OF LONG-ACTING INJECTABLE ANTIPSYCHOTICS AND THEIR ORAL OR SHORT-ACTING INJECTABLE FORMULATIONS

    May 1, 2020, 00:00

  • PMS41 THE ECONOMIC BURDEN OF MUSCULOSKELETAL DISORDERS RESULTING FROM ROAD TRAFIC ACCIDENT IN LOW AND MIDDLE INCOME COUNTRIES: A SYSTEMATIC REVIEW

    May 1, 2020, 00:00

  • PGI2 SYSTEMATIC REVIEW AND META-ANALYSIS OF INFLIXIMAB, ADALIMUMAB, GOLIMUMAB, VEDOLIZUMAB, AND TOFACITINIB FOR MODERATE-TO-SEVERE ULCERATIVE COLITIS IN ANTI-TNF-ALPHA-NAIVE PATIENTS

    May 1, 2020, 00:00

  • PDB27 THE DIABETES PREVENTION PROGRAM (DPP) QUALITY OF WELL BEING (QWB) UTILITY MEASURES AND MISSING DATA CONSIDERATIONS: AVAILABLE CASE ANALYSIS (ACA) VS. MANSKI LOWER AND UPPER BOUNDS (LMB AND UMB) RESULTS FOR UTILITIES AND QUALITY ADJUST ...

    May 1, 2020, 00:00

  • PIN22 MORTALITY, MORBIDITY AND BURDEN OF HOSPITALIZATIONS IN INFLUENZA PATIENTS WITH LOW AND HIGH COMORBIDITY INDEX: A PROPENSITY SCORE MATCHED ANALYSIS OF IN-PATIENT CLAIMS DATABASE

    May 1, 2020, 00:00

  • PDB2 HEALTH-RELATED QUALITY OF LIFE AND SLEEP QUALITY AMONG NORTH INDIAN TYPE 2 DIABETES MELLITUS PATIENTS: EVIDENCE FROM A CROSS-SECTIONAL STUDY

    May 1, 2020, 00:00

  • Mental Health - Clinical Outcomes

    May 1, 2020, 00:00

  • PMH25 CHARACTERISTICS AND HEALTHCARE RESOURCE UTILIZATION AMONG PATIENTS WITH MAJOR DEPRESSIVE DISORDER CONTINUING, SWITCHING, OR DISCONTINUING THERAPY IN A REAL-WORLD SETTING

    May 1, 2020, 00:00

  • PBI43 REAL-WORLD EVIDENCE RECOMMENDATIONS FOR GENE THERAPIES: REGULATORY VERSUS HEALTH TECHNOLOGY ASSESSMENT

    May 1, 2020, 00:00

  • PCN3 RETROSPECTIVE ELECTRONIC HEALTH RECORDS STUDY IN THE CANCERLINQ DISCOVERY DATABASE OF TREATMENT PATTERNS AMONG PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

    May 1, 2020, 00:00

  • PDB22 THE DIABETES PREVENTION PROGRAM (DPP) QUALITY OF WELL BEING (QWB) AND SF-6D UTILITY MEASURES AND MISSING DATA CONSIDERATIONS: AVAILABLE CASE ANALYSIS (ACA) VS. MANSKI LOWER AND UPPER BOUNDS (LMB AND UMB) RESULTS FOR UTILITIES AND QUAL ...

    May 1, 2020, 00:00

  • PDB51 IMPACT OF SENSOR AUGMENTED PUMP (SAP) IN TYPE 1 DIABETES MELLITUS (DMT1) PATIENTS IN COLOMBIA

    May 1, 2020, 00:00

  • PIH78 RASCH ANALYSIS OF THE STUDENT REFRACTIVE ERROR AND EYEGLASS QUESTIONNAIRE-R IN MYOPIC SCHOOL-AGED CHILDREN/CHILDREN AND YOUNG PEOPLE IN LONDON

    May 1, 2020, 00:00

  • PDB29 A COST-UTILITY ANALYSIS OF SODIUM-GLUCOSE COTRANSPORTER (SGLT) 2 INHIBITORS IN ADDITION TO BASAL-BOLUS INSULIN IN THE TREATMENT OF TYPE 1 DIABETES IN THE USA USING THE PRIME DIABETES MODEL

    May 1, 2020, 00:00

  • PIN3 RELATIVE VACCINE EFFECTIVENESS OF QUADRIVALENT CELL-BASED VERSUS EGG-BASED INFLUENZA VACCINES AMONG ADULTS 50-64 YEARS OLD: A U.S. OBSERVATIONAL COHORT STUDY

    May 1, 2020, 00:00

  • PMS74 THE EXAMINATION OF THE RELATIONSHIP BETWEEN BALANCE AND POSTURAL MUSCLES AMONG ELEMENTARY SCHOOL CHILDREN

    May 1, 2020, 00:00

  • PIH73 INFLUENCE OF MATERNAL MINDFULNESS TRAINING DURING PREGNANCY ON EXECUTIVE ABILITIES IN PRESCHOOL CHILDREN

    May 1, 2020, 00:00

  • PMS72 COMPUTERIZED ADAPTIVE TESTING OF ROUTINELY CAPTURED ORTHOPEDIC PRO MEASURES

    May 1, 2020, 00:00

  • PMD39 EFFICIENCY AND ECONOMIC ANALYSIS OF OPTICAL BIOMETERS: EXPERIENCE FROM A PRIVATE EYE MEDICAL CENTER IN THE UNITED STATES OF AMERICA

    May 1, 2020, 00:00

  • Copyright/Subscription

    May 1, 2020, 00:00

  • Diabetes/Endocrine/Metabolic Disorders - Real World Data Information Systems

    May 1, 2020, 00:00

  • PDG27 OUTPATIENT CEPHALOSPORIN USE IN A COLOMBIAN POPULATION: PRESCRIPTION-INDICATION STUDY

    May 1, 2020, 00:00

  • PMS28 COST-UTILITY ANALYSIS OF TREATMENT OPTIONS AFTER INITIAL TUMOR NECROSIS FACTOR INHIBITOR THERAPY FAILURE IN PATIENTS WITH RHEUMATOID ARTHRITIS

    May 1, 2020, 00:00

  • PCN11 REAL-WORLD TREATMENT PATTERNS IN RESECTABLE (STAGE I-IIIA) NON-SMALL CELL LUNG CANCER (NSCLC): A SYSTEMATIC LITERATURE REVIEW (SLR)

    May 1, 2020, 00:00

  • PDB38 BURDEN OF CARDIOVASCULAR DISEASE AND CARDIOVASCULAR (CV) RISK IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM): AN ANALYSIS OF A US HEALTH INSURANCE DATABASE

    May 1, 2020, 00:00

  • PMD40 FEMTOSECOND LASER ASSISTED CATARACT SURGERY: A REVIEW OF ITS EFFICIENCY COMPARED TO MANUAL CATARACT SURGERY

    May 1, 2020, 00:00

  • PMU36 COST-UTILITY ANALYSIS OF SINGLE DOSE GENE-REPLACEMENT THERAPY FOR SPINAL MUSCULAR ATROPHY TYPE 1 COMPARED TO CHRONIC NUSINERSEN TREATMENT IN JAPAN

    May 1, 2020, 00:00

  • PIH17 ECONOMIC IMPACT OF VAGUS NERVE STIMULATION THERAPY IN PEDIATRIC PATIENTS WITH DRUG-RESISTANT EPILEPSY

    May 1, 2020, 00:00

  • PIN44 SHORTENING TREATMENT FOR MULTIDRUG-RESISTANT TUBERCULOSIS IN BRAZIL: A COST-EFFECTIVENESS ANALYSIS

    May 1, 2020, 00:00

  • Cardiovascular Disorders - Health Service Delivery Process of Care

    May 1, 2020, 00:00

  • PDB43 QUALITY ADJUSTED LIFE YEARS (QALYS) IN THE DIABETES PREVENTION PROGRAM (DPP): QUALITY OF WELL BEING (QWB) VERSUS SF-6D INSTRUMENTS

    May 1, 2020, 00:00

  • PMS87 PROGRESSIVE SUBAQUAL TRAINING 3 MONTHS FOLLOW-UP IN FALL PREVENTION OF OSTEOPOROTIC PATIENT

    May 1, 2020, 00:00

  • PIT6 DISCRIMINATIVE ABILITY OF NEW INJURY SEVERITY SCORE TO PREDICT OUTCOMES AFTER FRACTURE REPAIRED SURGERY

    May 1, 2020, 00:00

  • PIH39 ASSOCIATION OF HEALTH-RELATED QUALITY OF LIFE AND PASSIVE SMOKE EXPOSURE IN PREGNANCY: EVIDENCE FROM A NATIONAL STUDY

    May 1, 2020, 00:00

  • Drugs Generics - Economic Evaluation

    May 1, 2020, 00:00

  • PDB16 A POPULATION-ADJUSTED INDIRECT COMPARISON OF CARDIOVASCULAR BENEFITS BETWEEN ONCE-WEEKLY SEMAGLUTIDE AND DULAGLUTIDE IN PATIENTS WITH TYPE 2 DIABETES AND HIGH CARDIOVASCULAR RISK

    May 1, 2020, 00:00

  • PMH32 PERCEPTION, PREVALENCE AND FACTORS ASSOCIATED TO SCHOOL BULLYING IN YOUNG PEOPLE FROM A POPULATION AFFILIATED IN A COLOMBIAN HEALTH SUBSIDIZED INSURANCE COMPANY IN 2018.

    May 1, 2020, 00:00

  • PCV61 EFFECTIVENESS OF A CARDIOVASCULAR RISK MANAGEMENT PROGRAM IN REDUCING THE PROBABILITY OF PREMATURE DEATH DUE TO CARDIOVASCULAR EVENTS IN THE COLOMBIAN CARIBBEAN REGION

    May 1, 2020, 00:00

  • PMD19 SYSTEMATIC LITERATURE REVIEW TO IDENTIFY THE CURRENT STATE OF KNOWLEDGE REGARDING HOME INFUSION VS MEDICAL-SETTING INFUSION

    May 1, 2020, 00:00

  • PIN30 ESTIMATED BUDGET IMPACT OF THE INTRODUCTION OF DOLUTEGRAVIR/LAMIVUDINE (DTG/3TC) IN THE UNITED STATES FOR THE TREATMENT OF HIV INFECTION

    May 1, 2020, 00:00

  • Biologics/Biosimilars/Regenerative Medicine - Epidemiology Public Health

    May 1, 2020, 00:00

  • PCV83 COMPARISON OF TREATMENT ADHERENCE AND PERSISTENCE WITH EDOXABAN VERSUS APIXABAN, DABIGATRAN, RIVAROXABAN, AND VITAMIN K ANTAGONIST IN NON-VALVULAR ATRIAL FIBRILLATION PATIENTS IN GERMANY: A PROPENSITY MATCHED COHORT STUDY

    May 1, 2020, 00:00

  • PIH9 BUDGET IMPACT ANALYSIS VS. COST EFFECTIVENESS ANALYSIS - HORMONAL CONTRACEPTIVES AS AN ILLUSTRATIVE CASE

    May 1, 2020, 00:00

  • PDG25 UTILIZATION OF PRESCRIPTION OPIOIDS AND BENZODIAZEPINES AMONG ARKANSANS WITH MEDICAL CANNABIS IDENTIFICATION CARDS: A MATCHED CONTROL STUDY

    May 1, 2020, 00:00

  • PIN75 IMMUNIZATIONS AND INJECTABLE MEDICATIONS: PHARMACISTS' INTEREST, ENGAGEMENT, AND REIMBURSEMENT PATTERNS IN MISSISSIPPI

    May 1, 2020, 00:00

  • PDB41 HOW MUCH DOES THERAPEUTIC INERTIA IN TYPE 2 DIABETES COST THE UK? A MODELING EVALUATION OF ECONOMIC BURDEN

    May 1, 2020, 00:00

  • PMU23 QUANTIFYING THE COSTS OF OBESITY-RELATED COMPLICATIONS IN THE UNITED STATES: A RETROSPECTIVE DATABASE STUDY

    May 1, 2020, 00:00

  • PGI7 EVALUATION OF LIVER OUTCOMES RELATIVE TO USE OF GLP-1 RECEPTOR AGONISTS (GLP1A) AND/OR SGLT-2 INHIBITORS (SGLT2I) IN REAL-WORLD POPULATIONS DIAGNOSED WITH TYPE II DIABETES (T2DM) AND NASH/NAFLD OR AT RISK OF NASH

    May 1, 2020, 00:00

  • Infectious Diseases - Clinical Outcomes

    May 1, 2020, 00:00

  • PBI26 RAPID REVIEW OF TRASTUZUMAB BIOSIMILARS COMPARED TO REFERENCE TRASTUZUMAB FOR BREAST CANCER TREATMENT IN NAIVE PATIENTS

    May 1, 2020, 00:00

  • PIH68 HEALTH-RELATED QUALITY OF LIFE MEASUREMENTS IN WOMEN WITH HYPOACTIVE SEXUAL DESIRE DISORDER: A SYSTEMATIC LITERATURE REVIEW

    May 1, 2020, 00:00

  • PBI16 COST ANALYSIS OF TWO TREATMENTS BY INFLIXIMAB (ORIGINATOR AND BIOSIMILAR) FOR PATIENTS WITH RHUMATOÏD ARTHRITIS (RA) OR INFLAMMATORY BOWEL DISEASE (IBD) IN A GROUP OF FRENCH PUBLIC HOSPITALS (UNIHA)

    May 1, 2020, 00:00

  • PIN26 ECONOMIC IMPACT IN DOMINICAN REPUBLIC SENASA OF 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE (PCV13) VERSUS NO VACCINATION IN OLDER ADULTS

    May 1, 2020, 00:00

  • PIN24 INCIDENCE AND COSTS OF INFLUENZA-RELATED HOSPITALIZATIONS BY COMORBIDITY IN THE UNITED STATES

    May 1, 2020, 00:00

  • PCV59 EPIDEMIOLOGICAL DISEASE BURDEN OF ACUTE MYOCARDIAL INFARCTION BASED ON ROUTINELY COLLECTED HEALTH INSURANCE CLAIMS DATA

    May 1, 2020, 00:00

  • PDB56 CONTRASTING THREE TYPE 2 DIABETES CARDIOVASCULAR RISK EQUATIONS FOR EAST ASIA WITH UKPDS82 USING THE IQVIA CORE DIABETES MODEL

    May 1, 2020, 00:00

  • PDB45 THE BUDGET IMPACT OF SITAGLIPTIN VERSUS ORAL SEMAGLUTIDE FROM A US PAYER PERSPECTIVE

    May 1, 2020, 00:00

  • PIN42 COMPARISON OF ECONOMIC BURDEN AND RISK OF HOSPITALIZATION AMONG HIV PATIENTS WITH AND WITHOUT HEPATITIS B COINFECTION IN THE VETERANS HEALTH ADMINISTRATION POPULATION

    May 1, 2020, 00:00

  • PDG31 THE PRICING AND SPENDING TRENDS OF ULTRA-EXPENSIVE DRUGS IN MEDICARE PART D PROGRAM

    May 1, 2020, 00:00

  • PDG66 QUALITY OF LIFE AND ADHERENCE OF PATIENTS TO ORAL NEUROLOGY SPECIALTY MEDICATIONS PROVIDED BY A SPECIALTY PHARMACY

    May 1, 2020, 00:00

  • PMS18 ANNUAL HEALTH INSURANCE TREATMENT COST OF INJURIES TO THE SHOULDER AND UPPER ARM BASED ON ROUTINELY COLLECTED REAL-WORLD FINANCING DATA

    May 1, 2020, 00:00

  • PMS76 ASSESSMENT OF HEALTH-RELATED QUALITY OF LIFE IN PATIENTS OF KNEE OSTEOARTHRITIS IN QUETTA, PAKISTAN

    May 1, 2020, 00:00

  • PBI9 BUDGET IMPACT ANALYSIS OF OBINUTUZUMAB-CHEMOTHERAPY FOLLOWED BY OBINUTUZUMAB MAINTENANCE COMPARED TO RITUXIMAB-CHEMOTHERAPY FOLLOWED BY RITUXIMAB MAINTENANCE IN A CHILEAN HEALTH PUBLIC SYSTEM SETTING FOR NON-HODGKIN-LYMPHOMA PATIENTS

    May 1, 2020, 00:00

  • PMS94 PREDICTORS OF IMPROVEMENT IN TENDER JOINT COUNTS AMONG PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS IN A LARGE, REPRESENTATIVE US-BASED REAL WORLD REGISTRY COHORT

    May 1, 2020, 00:00

  • PMH9 ESTIMATED COST-EFFECTIVENESS OF A 12-WEEK TREATMENT COURSE OF THE FIRST FDA-CLEARED PRESCRIPTION DIGITAL THERAPEUTIC FOR PATIENTS WITH OPIOID USE DISORDER

    May 1, 2020, 00:00

  • PCV72 DIFFERENTIAL USE OF TRANSCATHETER AORTIC VALVE IMPLANTS (TAVI). PERSONALIZATION STUDY

    May 1, 2020, 00:00

  • PDG16 A REVIEW OF THE EVIDENCE ON THE NET MONETARY BENEFIT OF SMOKING CESSATION INTERVENTIONS

    May 1, 2020, 00:00

  • PCV67 OPERATIONAL FEASIBILITY OF PHARMACIST GUIDED PERSONALIZED CONSULT SERVICE IN MANDATORY AND OPTIONAL SETTINGS

    May 1, 2020, 00:00

  • PGI3 LEAN AND OBESE PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS (NASH) / NON-ALCOHOLIC FATTY LIVER DISEASE (NALFD); COMPARISONS OF POPULATIONS AND DISEASE PROGRESSION

    May 1, 2020, 00:00

  • PIH3 ANGIOTENSIN I CONVERTING ENZYME INHIBITORS REDUCE RISK OF PNEUMONIA IN HOSPITALIZED ELDERLY PATIENTS

    May 1, 2020, 00:00

  • Infectious Diseases - Health Technology Assessment

    May 1, 2020, 00:00

  • PDG45 LOW-VALUE CARE: THE ASSOCIATION OF ANTIPSYCHOTIC POLYPHARMACY USE TO ECONOMIC BURDEN IN NON-INSTITUTIONALIZED CIVILIAN POPULATION IN THE UNITED STATES

    May 1, 2020, 00:00

  • PCV62 ASSOCIATED FACTORS TO THE CONTROL OF CARDIOVASCULAR RISK IN A LOW-INCOME POPULATION FROM THE CARIBBEAN REGION OF COLOMBIA

    May 1, 2020, 00:00

  • PIH23 A CLINICAL AND ECONOMIC ANALYSIS OF THE SINGLE-DOSE VERSUS MULTIPLE-DOSE APPROACHES OF SURFACTANT USE IN MECONIUM ASPIRATION SYNDROME IN NEONATAL INTENSIVE CARE UNITS IN QATAR

    May 1, 2020, 00:00

  • PBI41 LONGITUDINAL EVALUATION OF PRODUCT UTILIZATION AND CHARACTERISTICS AMONG PATIENTS TREATED WITH BIOLOGIC ANTI-INFLAMMATORY AGENTS: A STUDY BY THE BIOLOGICS AND BIOSIMILARS COLLECTIVE INTELLIGENCE CONSORTIUM

    May 1, 2020, 00:00

  • Individual's Health - Health Policy Regulatory

    May 1, 2020, 00:00

  • PMH66 THE BURDEN OF COST TO PATIENTS WITH OPIOID USE DISORDER TREATED WITH MEDICATION ASSISTED THERAPY: A SYSTEMATIC SCOPING REVIEW

    May 1, 2020, 00:00

  • PIH75 ASSESSMENT OF THE RATIONALITY OF PRESCRIBING IN ELDERLY INPATIENTS OF A SOUTH INDIAN HOSPITAL USING BEERS 2015 AND STOPP CRITERIA

    May 1, 2020, 00:00

  • PMU2 DEVELOPMENT AND USE OF SIMULATION-BASED TOOL INFORMING CLINICAL AND MARKET ACCESS STRATEGY

    May 1, 2020, 00:00

  • Injury Statistical Research

    May 1, 2020, 00:00

  • PDB48 THE COMPARISON OF SGLT2 INHIBITORS AND DPP-4 INHIBITORS ON HEALTH CARE EXPENDITURE AND UTILIZATION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

    May 1, 2020, 00:00

  • PMD3 ONE-YEAR COMPLICATIONS AND REIMBURSEMENT AFTER FIXATION WITH PLATING AND SCREWS FOR DISTAL FEMUR FRACTURES AMONG THE MEDICARE POPULATION

    May 1, 2020, 00:00

  • PMU64 IS THERE AN ASSOCIATION BETWEEN NON-COMMUNICABLE DISEASE MORTALITY AND CORRUPTION INDEXES? A GLOBAL PERSPECTIVE

    May 1, 2020, 00:00

  • Injury Trauma - Economic Evaluation

    May 1, 2020, 00:00

  • PIH40 INCIDENCE AND BURDEN OF RECURRENT VAGINITIS AMONG COMMERCIALLY INSURED WOMEN IN THE US

    May 1, 2020, 00:00

  • PCV70 CLINICAL DECISION SUPPORT INTERVENTIONS FOR PROMOTING GUIDELINE-CONCORDANT ANTICOAGULATION IN PATIENTS WITH ATRIAL FIBRILLATION: TARGETED LITERATURE REVIEW OF KEY FEATURES AND GAPS IN EVIDENCE

    May 1, 2020, 00:00

  • PMH71 VALUE-BASED HEALTHCARE: CAN ARTIFICIAL INTELLIGENCE IMPROVE THE MENTAL HEALTH WITH BRAZILIAN DATA?

    May 1, 2020, 00:00

  • PIN2 REAL-WORLD EFFECTIVENESS OF HEPATITIS C VIRUS (HCV) TREATMENT WITH DIRECT-ACTING ANTIVIRALS (DAA) IN POPULATIONS WITH FATTY LIVER/NON-ALCOHOLIC STEATOHEPATITIS (FL/NASH), DECOMPENSATED CIRRHOSIS (DCC), HEPATOCELLULAR CARCINOMA (HCC), A ...

    May 1, 2020, 00:00

  • PMS4 OUTPATIENT COSTS IN RHEUMATOID ARTHRITIS (RA) PATIENTS WITH VS WITHOUT COMORBIDITIES

    May 1, 2020, 00:00

  • PDB20 IS HYPOGLYCEMIA EXPENSIVE？

    May 1, 2020, 00:00

  • PDG18 DIFFERENCES IN RESOURCE UTILIZATION AND COSTS BETWEEN NARCOTIC USERS AND NON-NARCOTIC USERS FROM THE 2017 MEDICAL EXPENDITURE PANEL SURVEY

    May 1, 2020, 00:00

  • PIN54 MODELLING THE EFFECT OF TARGETED TREATMENT IN A TB OUTBREAK WITH COMPLEX CONTAGION

    May 1, 2020, 00:00

  • PBI7 BUDGET IMPACT ANALYSIS OF INTRODUCTION OF BEVACIZUMAB BIOSIMILAR IN THE UNITED STATES FROM A PAYER PERSPECTIVE

    May 1, 2020, 00:00

  • PMS22 ANNUAL HEALTH INSURANCE TREATMENT COST OF FEMORAL NECK FRACTURE BASED ON ROUTINELY COLLECTED, REAL-WORLD FINANCING DATA

    May 1, 2020, 00:00

  • PDG71 DOES LIPID LOWERING THERAPY UP-TITRATION IN OLDER ADULTS IMPACT ADHERENCE?

    May 1, 2020, 00:00

  • PGI22 ESTIMATING DIAGNOSTIC COSTS ASSOCIATED WITH A SECOND-GENERATION BLOOD TEST FOR ANTI-VINCULIN AND ANTI-CYTOLETHAL DISTENDING TOXIN B (CDTB) BIOMARKERS IN COMPARISON TO THE STANDARD EXCLUSIONARY APPROACH FOR IRRITABLE BOWEL SYNDROME WIT ...

    May 1, 2020, 00:00

  • PGI24 EPISODE OF CARE COSTS ASSOCIATED WITH MINIMALLY INVASIVE COLON SURGERY: A PROPENSITY-MATCHED ANALYSIS USING MEDICARE AND COMMERCIAL CLAIMS DATA

    May 1, 2020, 00:00

  • PBI27 TRENDS IN AVERAGE SALES PRICES OF BIOLOGICS REIMBURSED BY THE MEDICARE PART B PROGRAM (FIRST QUARTER 2010-FIRST QUARTER 2020)

    May 1, 2020, 00:00

  • PCV66 GUIDELINE-DIRECTED MEDICAL THERAPY AMONG HEART FAILURE PATIENTS FACILITATED BY NATURAL LANGUAGE PROCESSING OF AMBULATORY ELECTRONIC HEALTH RECORDS

    May 1, 2020, 00:00

  • Multiple Diseases - Economic Evaluation

    May 1, 2020, 00:00

  • PMS33 BUDGET IMPACT ANALYSIS OF KNEE JOINT REPLACEMENT DELAY IN PATIENTS WITH SEVERE KNEE OSTEOARTHRITIS TREATED WITH HYLAN GF-20, LOW MOLECULAR WEIGHT HYALURONATES AND CORTICOSTEROIDS IN COLOMBIA

    May 1, 2020, 00:00

  • Mental Health - Health Policy Regulatory

    May 1, 2020, 00:00

  • Individual's Health - Health Service Delivery Process of Care

    May 1, 2020, 00:00

  • PMS23 RATE AND REIMBURSEMENT OF 1-LEVEL AND 2+-LEVEL REOPERATIONS IN CERVICAL TOTAL DISC REPLACEMENT AND ANTERIOR CERVICAL DISCECTOMY AND FUSION

    May 1, 2020, 00:00

  • PMS11 MEDICAL RESOURCE USE IN PATIENTS WITH PSORIATIC ARTHRITIS IN A COMPREHENSIVE RHEUMATOLOGICAL CENTER IN COLOMBIA

    May 1, 2020, 00:00

  • PDG4 DESCRIPTION OF PRESCRIPTION OPIOID USE AMONG US ADULTS

    May 1, 2020, 00:00

  • PMU4 EVIDENCE FOR THE USABILITY OF THE E-TSQM

    May 1, 2020, 00:00

  • Biologics/Biosimilars/Regenerative Medicine - Health Service Delivery Process of Care

    May 1, 2020, 00:00

  • PMH28 ANTIPSYCHOTIC DRUG USE AMONG A US NATIONAL COHORT OF OLDER DEMENTIA PATIENTS USING ACETYLCHOLINESTERASE INHIBITORS

    May 1, 2020, 00:00

  • PDB74 EPIDEMIOLOGICAL DISEASE BURDEN OF NON-INSULIN-DEPENDENT DIABETES WITH MULTIPLE COMPLICATIONS BASED ON ROUTINELY COLLECTED HEALTH INSURANCE CLAIMS DATA

    May 1, 2020, 00:00

  • Mental Health - Epidemiology Public Health

    May 1, 2020, 00:00

  • PMD20 ECONOMIC IMPACT OF SPECIALIZED LABORATORY AUTOMATION ON THE TURNAROUND TIME (TAT) MEAN AND STANDARD DEVIATION

    May 1, 2020, 00:00

  • Medical Devices - Economic Evaluation

    May 1, 2020, 00:00

  • PGI39 INFLAMMATORY BOWEL DISEASE PATIENT'S TREATMENT PREFERENCES - USING QUALITATIVE PATIENT SURVEY DATA TO DEVELOP A DISCRETE CHOICE EXPERIMENT

    May 1, 2020, 00:00

  • PMS36 THE ECONOMIC BURDEN OF FIBROMYALGIA IN CHINA

    May 1, 2020, 00:00

  • PDB54 EVALUATING THE IMPACT OF POOR GLYCEMIC CONTROL ASSOCIATED WITH THERAPEUTIC INERTIA ON LIFE EXPECTANCY IN PATIENTS WITH TYPE 2 DIABETES IN THE UK

    May 1, 2020, 00:00

  • PIH50 FACTORS AND PATTERNS OF OFF-LABEL PRESCRIBING IN CHILDREN WITH ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) IN US. OUTPATIENT SETTINGS OVER A TEN-YEAR PERIOD

    May 1, 2020, 00:00

  • PMS44 THE ASSOCIATIONS BETWEEN PHYSICAL ACTIVITY AND COMORBIDITIES IN U.S OSTEOARTHRITIS PATIENTS: FINDINGS FROM THE NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY 2007 TO 2010

    May 1, 2020, 00:00

  • PMS2 RETROSPECTIVE ANALYSIS TO DETERMINE THE INCREASED RISK OF DEVELOPING OSTEOPOROSIS IN PATIENTS DIAGNOSED WITH DEPRESSION AND/OR PRESCRIBED ANTIDEPRESSANTS

    May 1, 2020, 00:00

  • Individual's Health - Economic Evaluation

    May 1, 2020, 00:00

  • PMH72 HEALTHCARE RESOURCE UTILIZATION (HRU) ASSOCIATED WITH EXTENDED-RELEASE NALTREXONE (XR-NTX) COMPARED WITH OTHER TREATMENTS IN PUBLICLY INSURED PATIENTS WITH OPIOID USE DISORDER (OUD)

    May 1, 2020, 00:00

  • PIN88 THE EXAMINATION OF THE PARENTAL DECISION ON CHOOSING VARICELLA VACCINATION

    May 1, 2020, 00:00

  • PMS82 PHYSICAL PARAMETERS AND THE FUNCTIONAL STATE OF THE SPINE IN AMATEUR TENNIS PLAYERS

    May 1, 2020, 00:00

  • PMS83 PILOT INVESTIGATION OF THE QUALITY OF LIFE AND SOCIO-DEMOGRAPHIC FACTORS OF PATIENTS UNDERWENT TOTAL HIP ARTHROPLASTY IN THE STATE HEALTH CARE SECTOR IN HUNGARY

    May 1, 2020, 00:00

  • PIN77 ASSESSING THE REAL-WORLD INPATIENT TREATMENT PARADIGM FOR RECURRENT CLOSTRIDIUM DIFFICILE

    May 1, 2020, 00:00

  • PIT7 DOES INTRAARTICULAR INVOLVEMENT INCREASE THE RISK OF COMPLICATIONS AFTER FRACTURE REPAIR SURGERY?

    May 1, 2020, 00:00

  • The EQ-5D-5L Value Set for England: Response to the “Quality Assurance”

    May 1, 2020, 00:00

  • Medical Devices - Health Technology Assessment

    May 1, 2020, 00:00

  • PMS49 EPIDEMIOLOGICAL DISEASE BURDEN OF SUBTROCHANTERIC FRACTURE BASED ON ROUTINELY COLLECTED HEALTH INSURANCE CLAIMS DATA

    May 1, 2020, 00:00

  • PGI17 COST EFFECTIVENESS ANALYSIS OF ENDOSCOPIC CAPSULE FOR DIAGNOSIS OF OBSCURE GASTROINTESTINAL BLEEDING IN THE BRAZILIAN PRIVATE HEALTHCARE SYSTEM

    May 1, 2020, 00:00

  • PDB55 ANNUAL HEALTH INSURANCE TREATMENT COST OF NON-INSULIN-DEPENDENT DIABETES WITH MULTIPLE COMPLICATIONS BASED ON ROUTINELY COLLECTED FINANCING DATA

    May 1, 2020, 00:00

  • PMD31 IS A SUPERFICIAL INFECTION AN INDEPENDENT PREDICTOR FOR A LATER DEEP INCISIONAL INFECTION IN TOTAL KNEE ARTHROPLASTY?

    May 1, 2020, 00:00

  • PMD9 COST-EFFECTIVENESS OF MOISTURE WICKING FABRIC IN THE TREATMENT OF INTERTRIGO COMPARED TO STANDARD OF CARE (SOC) IN A BRITISH CARE HOME SETTING USING A MARKOV DECISION MODEL

    May 1, 2020, 00:00

  • PCV87 HEART FAILURE RISK FACTORS ANALYSIS ON STABLE CORONARY ARTERY DISEASE PATIENTS IN CHINA

    May 1, 2020, 00:00

  • PBI2 EFFICACY AND SAFETY OF BIOLOGICS FOR THE TREATMENT OF ADULT PATIENTS WITH RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS IN RUSSIA: SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS

    May 1, 2020, 00:00

  • Individual's Health - Health Technology Assessment

    May 1, 2020, 00:00

  • PDB64 THERAPEUTIC INERTIA IN THE TREAMENT OF PATIENTS WITH TYPE 2 DIABETES IN A CARDIOVASCULAR RISK MANAGEMENT COHORT FROM THE CARIBBEAN REGION OF COLOMBIA

    May 1, 2020, 00:00

  • PMS16 ANNUAL HEALTH INSURANCE TREATMENT COST OF SCOLIOSIS BASED ON ROUTINELY COLLECTED REAL-WORLD FINANCING DATA

    May 1, 2020, 00:00

  • PMH70 OVERVIEW OF INDIVIDUALS WITH ANXIETY DISORDERS IN THE U.S. AND TREATMENT PATTERNS IN ANTI-ANXIETY MEDICATION REGIMENS.

    May 1, 2020, 00:00

  • PMU47 NOSOCOMIAL INFLUENZA HOSPITALIZATIONS AMONG END-STAGE RENAL DISEASE PATIENTS DURING THE 2013-2014 THROUGH 2015-2016 INFLUENZA SEASONS

    May 1, 2020, 00:00

  • PGI11 COMPARISON OF BURDEN OF HOSPITALIZATIONS IN INFLAMMATORY BOWEL DISEASE (IBD) WITH AND WITHOUT COLORECTAL CANCER: A PROPENSITY SCORE MATCHED ANALYSIS OF IN-PATIENT CLAIMS DATABASE

    May 1, 2020, 00:00

  • PMH51 WHAT ARE THE ATTRIBUTES THAT PSYCHIATRISTS CONSIDER IN THE DECISION TO DISCHARGE ADULTS WITH MAJOR DEPRESSIVE DISORDER WHO HAVE BEEN HOSPITALIZED WITH ACTIVE SUICIDAL IDEATION WITH INTENT?

    May 1, 2020, 00:00

  • PMU43 ASSOCIATION BETWEEN ATOPIC DISEASES AND ANEMIA IN KOREAN PATIENTS

    May 1, 2020, 00:00

  • PDB75 EFFECT OF CHRONIC EXPOSURE TO PSYCHOTROPIC MEDICATION ON THE INCIDENCE OF NEW-ONSET TYPE 2 DIABETES MELLITUS IN ADULTS, A RETROSPECTIVE COHORT STUDY USING PRESCRIPTION CLAIMS FROM COLOMBIA

    May 1, 2020, 00:00

  • PIH64 ADJUSTED INDIRECT COMPARISON OF THE MEDICINES USING IN CONTROLLED OVARIAN STIMULATION FOR ASSISTED REPRODUCTIVE TECHNOLOGY

    May 1, 2020, 00:00

  • PDB57 VALIDATION OF UKPDS OUTCOMES AND TAIWAN DIABETES MODELS ON TAIWAN TYPE 2 DM POPULATION

    May 1, 2020, 00:00

  • PMU26 COST-UTILITY ANALYSIS OF CANCER AND NON-CANCER CONDITIONS: A SYSTEMATIC REVIEW OF DIFFERENT LEVELS OF DISEASE PREVENTION AND CONTROL, 1990 TO 2016

    May 1, 2020, 00:00

  • Mental Health - Economic Evaluation

    May 1, 2020, 00:00

  • PMH27 ADHD TREATMENT AND DIAGNOSIS AMONG TEENAGE AND COLLEGE-AGED WOMEN

    May 1, 2020, 00:00

  • Biologics/Biosimilars/Regenerative Medicine - Clinical Outcomes

    May 1, 2020, 00:00

  • Alternative Medicine Public Health

    May 1, 2020, 00:00

  • PMD5 COMPARATIVE EFFECTIVENESS ASSESSMENT OF TWO POWERED SURGICAL STAPLING PLATFORMS IN LAPAROSCOPIC SLEEVE GASTRECTOMY

    May 1, 2020, 00:00

  • PMS67 DIFFERENCES IN HEALTHCARE EXPENDITURE BETWEEN OPIOID AND NON-OPIOID USERS AMONG A NATIONAL SAMPLE OF COMMUNITY-BASED OLDER UNITED STATES ADULTS WITH PAIN, 2015

    May 1, 2020, 00:00

  • PIH15 ANNUAL HEALTH INSURANCE TREATMENT COST OF ENDOMETRIOSIS BASED ON ROUTINELY COLLECTED FINANCING DATA

    May 1, 2020, 00:00

  • PIH72 PRENATAL MATERNAL STRESS CAN BE REDUCED BY MINDFULNESS TRAINING

    May 1, 2020, 00:00

  • PDG40 TRENDS IN UTILIZATION, REIMBURSEMENT, AND PRICE FOR ANTICOAGULANTS IN THE US MEDICAID POPULATION FROM 2000 TO 2018

    May 1, 2020, 00:00

  • PMH37 FACTORS INFLUENCING THE UPTAKE OF MENTAL HEALTH SERVICES IN SUB-SAHARAN AFRICA.

    May 1, 2020, 00:00

  • PIN59 17-YEAR DISEASE REDUCTION PREDICTED BY A TRANSMISSION DYNAMIC MODEL AFTER PNEUMOCOCCAL CONJUGATE VACCINE INTRODUCTION IN THE UNITED STATES

    May 1, 2020, 00:00

  • PBI18 BIOLOGIC THERAPIES FOR MODERATE-TO-SEVERE PSORIASIS: COST PER RESPONDER ANALYSIS CONSIDERING PRIVATE HEALTHCARE SYSTEM IN BRAZIL

    May 1, 2020, 00:00

  • Musculoskeletal Disorders - Epidemiology Public Health

    May 1, 2020, 00:00

  • PMU32 A DEVICE CATEGORY-BASED ECONOMIC MODEL EXPLORING ELECTROSURGERY TECHNOLOGIES ACROSS PROCEDURE TYPES: A CHINESE ANALYSIS

    May 1, 2020, 00:00

  • PDG44 COPRESCRIBING OF OPIOIDS AND BENZODIAZEPINES IN TEXAS MEDICAID ENROLLEES

    May 1, 2020, 00:00

  • PDB11 THE PERINATAL OUTCOMES AMONG WOMEN WITH TWIN PREGNANCIES: PROPENSITY SCORE MATCHED ANALYSIS FROM A SEVEN-YEAR RETROSPECTIVE COHORT

    May 1, 2020, 00:00

  • PBI34 IMPACTS OF LONG-TERM UNCERTAINTY AND FAMILY SPILLOVER EFFECTS ON THE COST-UTILITY OF APPROVED TREATMENTS FOR SMA TYPE I

    May 1, 2020, 00:00

  • Multiple Diseases - Clinical Outcomes

    May 1, 2020, 00:00

  • PMS89 A REAL-WORLD STUDY OF THE PATIENT EXPERIENCE WITH ABALOPARATIDE

    May 1, 2020, 00:00

  • PIH66 ASSOCIATION BETWEEN MEDICATION BURDEN AND ADHD MEDICATION ADHERENCE IN A PEDIATRIC POPULATION WITH MULTIPLE CHRONIC CONDITIONS

    May 1, 2020, 00:00

  • PDG67 PREDICTORS OF CHRONIC MEDICATION NONADHERENCE IN CANCER SURVIVORS: A SYSTEMATIC LITERATURE REVIEW

    May 1, 2020, 00:00

  • PDG26 THE ASSOCIATION OF BETA-BLOCKERS USE TO CHRONIC PAIN AMONG ADULTS WITH CARDIOVASCULAR DISEASES (CVD) OR HYPERTENSION IN THE UNITED STATES

    May 1, 2020, 00:00

  • Defining Comparators According to IQWiG’s Efficiency-Frontier Method

    May 1, 2020, 00:00

  • PIH59 ADHERENCE TO TREATMENT FOR POLYCYSTIC OVARIAN SYNDROME: A SYSTEMATIC REVIEW

    May 1, 2020, 00:00

  • Alternative Medicine Nutrition - Clinical Outcomes

    May 1, 2020, 00:00

  • PMS3 LORECEVIVINT, A POTENTIAL DISEASE-MODIFYING TREATMENT FOR KNEE OSTEOARTHRITIS: FACTORS DRIVING WOMAC PAIN SUBSCORE CHANGES - A POST HOC ANALYSIS OF PHASE 2B DATA

    May 1, 2020, 00:00

  • Musculoskeletal Disorders - Health Technology Assessment

    May 1, 2020, 00:00

  • PDB46 ELEVATED ANNUAL HEALTHCARE UTILIZATION AND DIRECT MEDICAL COSTS ASSOCIATED WITH DIABETES MELLITUS PATIENTS WITH OSTEOPOROSIS IN CHINA

    May 1, 2020, 00:00

  • PDB12 EFFICACY AND SAFETY OF ETELCALCETIDE IN THE TREATMENT OF SECONDARY HYPERPARATHYROIDISM IN ADULT PATIENTS WITH CHRONIC KIDNEY DISEASE UNDERGOING DIALYSIS: A SYSTEMATIC REVIEW AND META-ANALYSIS

    May 1, 2020, 00:00

  • PBI20 COMPARISON OF DECISION MODELING APPROACHES FOR HEALTH TECHNOLOGY AND POLICY EVALUATION

    May 1, 2020, 00:00

  • PMU58 SMART SPENDING: REALLOCATING AMERICANS’ FOOD BUDGETS TO SAVE COSTS AND IMPROVE DIET QUALITY

    May 1, 2020, 00:00

  • PMU28 CLINICAL AND ECONOMIC OUTCOMES OF CARBAPENEM-RESISTANT GRAM-NEGATIVE ORGANISMS: A MULTICENTER STUDY IN CHINA

    May 1, 2020, 00:00

  • PDB59 THE IMPACT OF HYPERKALAEMIA AND ITS CONCURRENCE WITH CARDIORENAL COMORBIDITIES ON HEALTHCARE RESOURCE USE IN THE UK

    May 1, 2020, 00:00

  • PIN73 KNOWLEDGE OF TUBERCULOSIS AMONG PATENT AND PROPRIETARY MEDICINE VENDORS IN RURAL AREAS OF ENUGU STATE IN SOUTHEAST NIGERIA

    May 1, 2020, 00:00

  • Gastrointestinal Disorders - Economic Evaluation

    May 1, 2020, 00:00

  • PMH45 DISPARITIES IN TREATMENT ADMISSIONS FOR OPIOID USE DISORDER IN CINCINNATI BY RACE

    May 1, 2020, 00:00

  • PGI30 WEB-BASED RESEARCH OF QUALITY OF LIFE OUTCOME AND STATUS OF MEDICAL EXPENSE SUBSIDY FOR INTRACTABLE DISEASE FOR PATIENTS WITH INFLAMMATORY BOWEL DISEASE IN JAPAN

    May 1, 2020, 00:00

  • PIH82 PREVALENCE AND PREDICTORS OF POLYPHARMACY AND POTENTIALLY INAPPROPRIATE MEDICATIONS IN A LARGE COMMUNITY-DWELLING OLDER POPULATION IN ITALY

    May 1, 2020, 00:00

  • PMS55 EPIDEMIOLOGICAL DISEASE BURDEN OF INJURIES TO THE KNEE AND LOWER LEG BASED ON ROUTINELY COLLECTED HEALTH INSURANCE CLAIMS DATA

    May 1, 2020, 00:00

  • PCV64 IMPACT ON ANTIHYPERTENSIVE PRESCRIBING AFTER THE DEAR HEALTHCARE PROFESSIONAL LETTER ON INCREASED RISK OF SKIN CANCER RELATED TO HYDROCHLOROTHIAZIDE

    May 1, 2020, 00:00

  • PDG52 CONCOMITANT USE OF OPIOIDS AND CENTRAL NERVOUS SYSTEM DEPRESSANTS IN PATIENTS WITH NONMALIGNANT CHRONIC PAIN AND ADHERENCE TO FOOD AND DRUG ADMINISTRATION WARNING

    May 1, 2020, 00:00

  • PMS34 TALTZ® (IXEKIZUMAB) FOR TREATMENT OF PSORIATIC ARTHRITIS IN THE UNITED STATES: A BUDGET IMPACT ANALYSIS

    May 1, 2020, 00:00

  • PIN13 ESTIMATING THE IMPACT OF A GENDER-NEUTRAL QUADRIVALENT HUMAN PAPILLOMAVIRUS VACCINATION PROGRAM IN ALL HPV 6/11/16/18 -RELATED DISEASES IN COLOMBIA

    May 1, 2020, 00:00

  • PMH23 ECONOMIC BURDEN OF SCHIZOPHRENIA AMONG YOUNG ADULTS WITH MEDICAID COVERAGE

    May 1, 2020, 00:00

  • PBI35 HEALTH TECHNOLOGY ASSESSMENT (HTA) REVIEW OF CELL GENE THERAPIES: THE ROAD TO REIMBURSEMENT

    May 1, 2020, 00:00

  • PIH27 DIAGNOSING NEWBORNS WITH SUSPECTED SEVERE MITOCHONDRIAL DISORDERS: A COST-EFFECTIVENESS STUDY COMPARING EARLY WHOLE EXOME SEQUENCING TO STANDARD OF CARE

    May 1, 2020, 00:00

  • PIN15 BUDGETARY IMPACT ANALYSIS OF SHORTENING TREATMENT FOR MULTIDRUG-RESISTANT TUBERCULOSIS IN BRAZIL

    May 1, 2020, 00:00

  • PMD53 COMPARISON OF WOUND CLOSURE IN SURGICAL WOUNDS BETWEEN SINGLE-USE NEGATIVE PRESSURE WOUND THERAPY AND TRADITIONAL NEGATIVE PRESSURE WOUND THERAPY: A REAL WORLD ANALYSIS

    May 1, 2020, 00:00

  • PMD25 EVALUATING BUDGET IMPACT OF PERIPROSTHETIC JOINT INFECTION DIAGNOSIS PATHWAYS IN TOTAL HIP AND KNEE ARTHROPLASTY PATIENTS

    May 1, 2020, 00:00

  • PMU16 IN-HOSPITAL OUTCOMES ASSOCIATED WITH HEART FAILURE AMONG WOMEN WITH BREAST CANCER IN THE U.S.: AN ANALYSIS OF THE 2012-2016 NATIONAL INPATIENT SAMPLE

    May 1, 2020, 00:00

  • PIH8 UNDERSTANDING THE ECONOMIC BURDEN OF COMORBIDITIES ASSOCIATED WITH MALE HYPOGONADISM: A COST MODEL IN ENGLAND

    May 1, 2020, 00:00

  • PDB65 EPIDEMIOLOGICAL DISEASE BURDEN OF NON-INSULIN-DEPENDENT DIABETES WITH COMPLICATIONS BASED ON ROUTINELY COLLECTED HEALTH INSURANCE CLAIMS DATA

    May 1, 2020, 00:00

  • PMU14 THE USE OF PERSPECTIVE AND COSTING APPROACHES IN COST-EFFECTIVENESS ANALYSIS

    May 1, 2020, 00:00

  • PIH24 A CLINICAL AND ECONOMIC EVALUATION OF SURFACTANT THERAPY FOR MECONIUM ASPIRATION SYNDROME IN THE NEONATAL INTENSIVE CARE SETTING IN QATAR

    May 1, 2020, 00:00

  • Diabetes/Endocrine/Metabolic Disorders - Epidemiology Public Health

    May 1, 2020, 00:00

  • PMH59 COMPLEX EXAMINATION OF THE MENTAL HEALTH OF TEACHERS

    May 1, 2020, 00:00

  • PIH18 POLYPHARMACY, HEALTHCARE EXPENDITURES AND HEALTH STATUS AMONG OLDER ADULTS WITH CARDIAC DISEASE

    May 1, 2020, 00:00

  • Biologics/Biosimilars/Regenerative Medicine - Health Technology Assessment

    May 1, 2020, 00:00

  • Cardiovascular Disorders - Patient-Centered Research

    May 1, 2020, 00:00

  • PMH67 CAPTURING PATIENT EXPERIENCE AS A KEY TO BETTER OUTCOMES: THE IMPORTANCE OF COGNITIVE APPRAISAL PROCESSES IN ENABLING RESILIENCE AMONG DEPRESSED INDIVIDUALS

    May 1, 2020, 00:00

  • PIN38 COST-EFFECTIVENESS OF TESAMORELIN IN THE TREATMENT OF LIPOHYPERTROPHY IN THE US

    May 1, 2020, 00:00

  • Infectious Diseases - Medical Technologies

    May 1, 2020, 00:00

  • PDG24 OPIOID-RELATED OVERDOSE IN PATIENTS WITH CONCURRENT USE OF OPIOIDS AND BENZODIAZEPINES: A NESTED CASE-CONTROL STUDY OF COMMERCIALLY INSURED PATIENTS

    May 1, 2020, 00:00

  • PMD30 HETEROGENEITY OF PATIENTS TREATED WITH MULTI-PLANAR SOFTWARE-ASSISTED EXTERNAL FIXATION SYSTEMS (SPATIAL FRAMES) - ANALYSES OF PATIENT VARIABILITY AND OPERATIVE COMPLICATIONS

    May 1, 2020, 00:00

  • PCN7 COMPARATIVE EFFECTIVENESS OF GRANULOCYTE COLONY STIMULATING FACTOR UTILIZATION VERSUS CHEMOTHERAPY DOSE REDUCTION ON OVERALL SURVIVAL: A PROPENSITY SCORE MATCHED ANALYSIS

    May 1, 2020, 00:00

  • Investigation Into the Effects of Using Normal Distribution Theory Methodology for Likert Scale Patient-Reported Outcome Data From Varying Underlying Distributions Including Floor/Ceiling Effects

    May 1, 2020, 00:00

  • PGI13 A BUDGET IMPACT ANALYSIS OF FIDAXOMICIN FOR THE MANAGEMENT OF CLOSTRIDIOIDES DIFFICILE INFECTION IN THE UNITED STATES

    May 1, 2020, 00:00

  • PMD47 THE CHOICES COMPARATIVE TRIAL: FACILITY COST AND OUTCOMES ANALYSIS OF MYOMECTOMY COMPARED TO TREATMENT WITH THE SONATA SYSTEM

    May 1, 2020, 00:00

  • PMS42 HEALTHCARE EXPENDITURE HEALTH-RELATED QUALITY OF LIFE OF MUSCULOSKELETAL PAIN PATIENTS ON OPIOIDS VERSUS NSAIDS

    May 1, 2020, 00:00

  • PMD54 COMPARISON OF WOUND CLOSURE IN PRESSURE ULCERS BETWEEN SINGLE-USE NEGATIVE PRESSURE WOUND THERAPY AND TRADITIONAL NEGATIVE PRESSURE WOUND THERAPY: A REAL WORLD ANALYSIS

    May 1, 2020, 00:00

  • PMS12 HEALTHCARE RESOURCE UTILIZATION ASSOCIATED WITH GIANT CELL ARTERITIS IN THE UNITED STATES

    May 1, 2020, 00:00

  • PBI19 BUDGET IMPACT ANALYSIS OF IXEKIZUMAB, GUSELKUMAB, RISANKIZUMAB AND/OR SECUKINUMAB FOR MANAGEMENT OF MODERATE-TO-SEVERE PSORIASIS IN THE KINGDOM OF SAUDI ARABIA

    May 1, 2020, 00:00

  • PDB39 COST-EFFECTIVENESS OF EMPAGLIFLOZIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN ARGENTINA

    May 1, 2020, 00:00

  • Individual's Health - Methodological Statistical Research

    May 1, 2020, 00:00

  • PDG38 ASSESSMENT OF GENERIC COMPETITION FOR ORPHAN DRUGS MARKETED IN THE US (1993-2019)

    May 1, 2020, 00:00

  • PIH69 THE NEED FOR PERSON-CENTRED CARE IN ENDOMETRIOSIS TREATMENT: QUALITATIVE INSIGHTS AND DISCRETE CHOICE EXPERIMENT DEVELOPMENT

    May 1, 2020, 00:00

  • PDB10 EVALUATION OF THE RATE OF PREVENTABLE DIABETES-RELATED HOSPITALIZATIONS IN MEDICAID

    May 1, 2020, 00:00

  • PMD15 ASSESSMENT OF THE RISK AND ECONOMIC BURDEN OF SURGICAL SITE INFECTION FOLLOWING COLORECTAL SURGERY USING A US LONGITUDINAL DATABASE: IS THERE A ROLE FOR INNOVATIVE ANTIMICROBIAL WOUND CLOSURE TECHNOLOGY TO REDUCE THE RISK OF INFECTION ...

    May 1, 2020, 00:00

  • PMS79 PHASE 1B EVALUATION OF PATIENT EXPERIENCE WITH ABALOPARATIDE SOLID MICROSTRUCTURED TRANSDERMAL SYSTEM IN POSTMENOPAUSAL WOMEN WITH LOW BONE MINERAL DENSITY

    May 1, 2020, 00:00

  • PMU52 CLINICAL ADOPTION OF GENOMIC TESTING IN ONCOLOGY: A TARGETED LITERATURE REVIEW OF THE GLOBAL PAYER LANDSCAPE

    May 1, 2020, 00:00

  • PBI3 TRANSFUSION-RELATED ABO INCOMPATIBILITY REACTIONS AMONG THE INPATIENT U.S. MEDICARE BENEFICIARIES, AGES 65 AND OLDER, DURING 2007-2018

    May 1, 2020, 00:00

  • PDB42 BUDGET IMPACT ANALYSIS OF SENSOR-AUGMENTED PUMP IN TYPE 1 DIABETES MELLITUS COMPARED WITH CONTINUOUS SUBCUTANEOUS INSULIN INFUSION IN THE RUSSIAN FEDERATION

    May 1, 2020, 00:00

  • Comparative Effectiveness Studies Methods

    May 1, 2020, 00:00

  • PIH63 THE EFFICACY OF TREATMENTS FOR ATOPIC DERMATITIS IN CHILDREN: A NETWORK META-ANALYSIS

    May 1, 2020, 00:00

  • PCV88 THE APPLICATION OF BAYESIAN HETEROGENEITY TREATMENT EFFECT ANALYSIS FOR ASSESSING VARIATION AND RELIABILITY OF CONGESTIVE HEART FAILURE OUTCOMES IN A LINKED EMR-CLAIMS DATASET

    May 1, 2020, 00:00

  • PDG63 FACTORS ASSOCIATED WITH SLEEPING MEDICATION USE AMONG ADULTS IN THE UNITED STATES

    May 1, 2020, 00:00

  • PCN14 UPDATED NETWORK META-ANALYSIS OF FIRST-LINE EGFR-TARGETED TYROSINE KINASE INHIBITOR TREATMENTS FOR LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER WITH EGFR-ACTIVATING MUTATIONS

    May 1, 2020, 00:00

  • PMU7 IS THE TREATMENT SATISFACTION QUESTIONNAIRE FOR MEDICATION FIT-FOR-PURPOSE?: A MIXED-METHODS APPROACH

    May 1, 2020, 00:00

  • PAM2 ORAL NUTRITIONAL SUPPLEMENTATION CAN IMPROVE POSTOPERATIVE OUTCOMES FOR COLORECTAL SURGERY PATIENTS

    May 1, 2020, 00:00

  • PB2 ADHERENCE TO INJECTABLE ANTIDIABETIC THERAPIES (IAT) AMONG PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM) IN CHINA: RESULTS FROM A CROSS-SECTIONAL SURVEY STUDY

    May 1, 2020, 00:00

  • PIN6 CLINICAL BENEFITS AND COST SAVINGS FROM IMPLEMENTING A SIMPLIFIED STRATEGY FOR GLECAPREVIR/PIBRENTASVIR (G/P) 8-WEEK TREATMENT IN NON-CIRRHOTIC NAÃVE PATIENTS WITH HEPATITIS C. THE JUST SIMPLE STUDY (REAL CLINICAL PRACTICE IN SPAIN).

    May 1, 2020, 00:00

  • PDG57 EFFICACY AND SAFETY OF FLAVONOIDS IN ADULT PATIENTS WITH HEMORRHOIDS: A SYSTEMATIC REVIEW

    May 1, 2020, 00:00

  • PCV65 HOSPITALIZATIONS AND MORTALITY AMONG CARDIAC AMYLOIDOSIS PATIENTS COVERED BY MEDICARE ADVANTAGE

    May 1, 2020, 00:00

  • PMD28 PERIOPERATIVE OUTCOME COMPARISON FOLLOWING UNILATERAL AND SIMULTANEOUS BILATERAL TOTAL KNEE ARTHROPLASTY

    May 1, 2020, 00:00

  • PDG32 GAME-THEORETICAL ANALYSIS OF NETFLIX PAYMENT MODEL FOR HEPATITIS C TREATMENT

    May 1, 2020, 00:00

  • PDG20 HEALTHCARE RESOURCE UTILIZATION AND COSTS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES TREATED WITH HYPOMETHYLATING AGENTS: A SEER-MEDICARE ANALYSIS

    May 1, 2020, 00:00

  • PDB83 THE ROLE OF HEALTH CARE PROVIDER'S ADVICE IN PREDIABETES MANAGEMENT IN THE US

    May 1, 2020, 00:00

  • PDG7 COST-EFFECTIVENESS ANALYSIS OF SULODEXIDE VERSUS DIOSMIN IN THE TREATMENT OF CHRONIC VENOUS INSUFFICIENCY IN CHINA

    May 1, 2020, 00:00

  • Alternative Medicine Statistical Research

    May 1, 2020, 00:00

  • PDG10 COST-EFFECTIVENESS OF CELECOXIB VERSUS IBUPROFEN AND NAPROXEN IN PATIENTS WITH OSTEOARTHRITIS IN UNITED ARAB EMIRATES AND SAUDI ARABIA BASED ON RESULTS FROM THE PRECISION TRIAL

    May 1, 2020, 00:00

  • Injury Public Health

    May 1, 2020, 00:00

  • PIH44 EPIDEMIOLOGICAL DISEASE BURDEN OF FEMALE INFERTILITY BASED ON ROUTINELY COLLECTED HEALTH INSURANCE CLAIMS DATA

    May 1, 2020, 00:00

  • PDG33 CHANGES IN SCHEDULE II ORAL OPIOID VOLUME DISPENSED IN A PRIVATE PAYER FOLLOWING FLORIDA’S ACUTE PAIN OPIOID RESTRICTION LAW

    May 1, 2020, 00:00

  • PIN35 UTILIZATION, SPENDING AND PRICE TRENDS FOR ANTIVIRAL (FLU AGENTS) IN THE US MEDICAID PROGRAMS: EMPIRICAL DATA ANALYSIS FROM 1999-2018.

    May 1, 2020, 00:00

  • PMS30 ANNUAL HEALTH INSURANCE TREATMENT COST OF SUBTROCHANTERIC FRACTURE BASED ON ROUTINELY COLLECTED REAL-WORLD FINANCING DATA

    May 1, 2020, 00:00

  • PDG29 DROSPIRENONE INDUCED GALL BLADDER DISEASES: A RETROSPECTIVE STUDY OF EUDRAVIGILANCE DATABASE

    May 1, 2020, 00:00

  • PMS19 A SYSTEMATIC REVIEW OF ECONOMIC MODELS FOR COST EFFECTIVENESS OF PHYSIOTHERAPY INTERVENTION FOLLOWING TOTAL KNEE AND HIP REPLACEMENT

    May 1, 2020, 00:00

  • PIH36 TIME TO CONFIRMATORY TESTING OF CHILDREN AGE 72 MONTHS FOR ELEVATED BLOOD LEAD

    May 1, 2020, 00:00

  • PMU15 RETROSPECTIVE STUDY EXAMINING HEALTH CARE UTILIZATION AND COSTS FOR PATIENTS WITH PSORIASIS AND PSORIATIC ARTHRITIS IN THE US

    May 1, 2020, 00:00

  • PGI21 COST PER ACCEPTABLE LIFE-YEARS AND COST PER QALY GAINS IN NON-ACCEPTABLE HEALTH STATE FOR BIOLOGICAL TREATMENT IN CROHN'S DISEASE, A NOVEL APPROACH IN HEALTH ECONOMIC MODELLING

    May 1, 2020, 00:00

  • PCV86 EXAMINING PREDICTORS OF DURATION OF INITIAL ANTIHYPERTENSIVE THERAPY

    May 1, 2020, 00:00

  • PMD45 COMPARISON OF WOUND CLOSURE IN CHRONIC LOWER EXTREMITY ULCERS BETWEEN SINGLE-USE NEGATIVE PRESSURE WOUND THERAPY AND TRADITIONAL NEGATIVE PRESSURE WOUND THERAPY: A REAL WORLD ANALYSIS

    May 1, 2020, 00:00

  • PDB111 A COMPARATIVE EFFECTIVENESS RESEARCH STUDY OF A NATIVE TYPE I COLLAGEN MATRIX PLUS POLYHEXAMETHYLENE BIGUANIDE ANTIMICROBIAL AND A CRYOPRESERVED CADAVERIC SKIN ALLOGRAFT FOR USE IN DIABETIC FOOT ULCERS - A NON-INFERIORITY ANALYSIS

    May 1, 2020, 00:00

  • PMU45 FACTORS ASSOCIATED WITH NEGATIVE SELF RATED HEALTH (SRH) IN A PRIVATE HEALTH PLAN IN BRAZIL

    May 1, 2020, 00:00

  • PMD22 BUDGET IMPACT ANALYSIS OF THE INCORPORATION OF MECHANICAL THROMBECTOMY WITH STENT RETRIEVERS AFTER THROMBOLYSIS IN ISCHEMIC-STROKE WITH LARGE VESSEL OCCLUSION IN THE CHILEAN PUBLIC SECTOR.

    May 1, 2020, 00:00

  • PIN36 BUDGETARY IMPACT ANALYSIS OF PREEXPOSURE PROPHYLAXIS (PREP) STRATEGY FOR THE PREVENTION OF HIV IN COLOMBIA, 2019-2021

    May 1, 2020, 00:00

  • Cardiovascular Disorders - Health Technology Assessment

    May 1, 2020, 00:00

  • PMH8 EFFECT OF DEPRESSION ON WORK PRODUCTIVITY COSTS AND EMPLOYMENT

    May 1, 2020, 00:00

  • PDB66 DEFINING DIABETES MELLITUS USING ADMINISTRATIVE CLAIMS DATA

    May 1, 2020, 00:00

  • PCV56 COMPARISON OF THE FRAMINGHAM, PROCAM AND MODIFIED FRAMINGHAM RISK SCORES FOR PREDICTING CARDIOVASCULAR EVENTS IN A COHORT FROM A CARDIOVASCULAR PREVENTION PROGRAM IN THE CARIBBEAN REGION OF COLOMBIA

    May 1, 2020, 00:00

  • PBI42 DISCONTINUATION PLAYS A ROLE WHEN EVALUATING THE COST EFFECTIVENESS OF THE SECOND BIOLOGICAL DRUG FOR PATIENTS WITH RHEUMATOID ARTHRITIS

    May 1, 2020, 00:00

  • PDB69 FACTORS ASSOCIATED WITH PRE-DIABETES IN THE U.S ‘DIABETES-BELT’ REGION POPULATION

    May 1, 2020, 00:00

  • PBI17 BUDGET IMPACT ANALYSIS OF INTRODUCTION OF RITUXIMAB BIOSIMILAR IN THE UNITED STATES FROM A PAYER PERSPECTIVE

    May 1, 2020, 00:00

  • PDG15 ECONOMIC ASSESSMENT OF SWITCHING FROM DIPEPTIDYL PEPTIDASE-4 INHIBITORS TO SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITORS OR GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST USING REAL-WORLD DATA

    May 1, 2020, 00:00

  • PIN79 VACCINATION COVERAGE RATE: WHAT CAN WE EXPECT FROM BRAZIL?

    May 1, 2020, 00:00

  • Advanced Analytics Studies

    May 1, 2020, 00:00

  • PMU30 COST-EFFECTIVENESS ANALYSIS OF NEWBORN SCREENING FOR SPINAL MUSCULAR ATROPHY (SMA) IN THE UNITED STATES

    May 1, 2020, 00:00

  • PMS25 CLINICAL VALIDATION OF A BUDGET IMPACT MODEL USING THE ESTABLISHED KEY OPINION LEADER VALIDATION FRAMEWORK (KOLVF)

    May 1, 2020, 00:00

  • PDB35 A COST MINIMIZATION ANALYSIS OF NEGATIVE PRESSURE WOUND THERAPY TECHNOLOGIES FOR THE TREATMENT OF MODERATE TO SEVERE FOOT INFECTIONS

    May 1, 2020, 00:00

  • PMU20 A DEVICE CATEGORY-BASED ECONOMIC MODEL EXPLORING ELECTROSURGERY TECHNOLOGIES ACROSS PROCEDURE TYPES: A UNITED STATES ANALYSIS

    May 1, 2020, 00:00

  • PBI10 BUDGET IMPACT ANALYSIS OF MEPOLIZUMAB AS AN ADD-ON THERAPY IN THE TREATMENT OF SEVERE EOSINOPHILIC ASTHMA IN CHILE

    May 1, 2020, 00:00

  • PIN57 UPTAKE OF PRE-EXPOSURE PROPHYLAXIS (PREP) AND TYPE OF PROVIDERS AMONG COMMERCIALLY-INSURED PERSONS IN THE UNITED STATES, 2012-2018

    May 1, 2020, 00:00

  • PMD26 A COST-EFFECTIVENESS AND SENSITIVITY ANALYSIS OF METAL NEEDLES COMPARED WITH PLASTIC FISTULA CANNULAS FOR HEMODIALYSIS PATIENTS IN MEXICO, CONSIDERING NEEDLE-INDUCED INJURY REQUIRING INTERVENTION

    May 1, 2020, 00:00

  • PDB93 NAFLD SIMULATOR: A WEB-BASED SIMULATION TOOL TO PREDICT LONG-TERM OUTCOMES OF NON-ALCOHOLIC FATTY LIVER DISEASE

    May 1, 2020, 00:00

  • PMH24 BUDGET IMPACT ANALYSIS OF VORTIOXETINE AND/OR SERTRALINE USE FOR MANAGEMENT OF MAJOR DEPRESSIVE DISORDER IN THE KINGDOM OF SAUDI ARABIA

    May 1, 2020, 00:00

  • PIH10 COST-EFFECTIVENESS ANALYSIS OF IMRECOXIB, CELECOXIB AND DICLOFENAC IN OSTEOARTHRITIS IN CHINA

    May 1, 2020, 00:00

  • PDB34 THE DIABETES PREVENTION PROGRAM (DPP) QUALITY OF WELL BEING (QWB) UTILITY MEASURES AND MISSING DATA CONSIDERATIONS: AVAILABLE CASE ANALYSIS (ACA) VS. MULTIPLE IMPUTATION (MI) RESULTS FOR UTILITIES AND QUALITY ADJUSTED LIFE YEARS (QALY ...

    May 1, 2020, 00:00

  • PCV68 PREDICTORS OF FAILURE-TO-RESCUE FOR ACUTE MYOCARDIAL INFARCTION

    May 1, 2020, 00:00

  • Diabetes/Endocrine/Metabolic Disorders - Economic Evaluation

    May 1, 2020, 00:00

  • PDG56 APPLICATION OF HEALTH TECHNOLOGY ASSESSMENT IN CHINA NATIONAL REIMBURSEMENT DRUG LIST PRICE NEGOTIATIONS: THE EVOLVING TREND AND IMPLICATIONS

    May 1, 2020, 00:00

  • PIN60 VISUALIZING THE IMMUNIZATION RATES IN NIGERIA: MAPPING THE CRISIS TO TARGET RESOURCES ALLOCATION

    May 1, 2020, 00:00

  • PDG3 EVALUATION OF PROGESTERONE (17-ALPHA HYDROXYPROGESTERONE CAPROATE (17-OHPC)) UTILIZATION, ADHERENCE, AND OUTCOMES IN WOMEN WITH A HIGH-RISK PREGNANCY

    May 1, 2020, 00:00

  • PIN51 FACTORS ASSOCIATED WITH INCREASED RISK OF HERPES ZOSTER AMONG PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE

    May 1, 2020, 00:00

  • Alternative Medicine Nutrition - Economic Evaluation

    May 1, 2020, 00:00

  • Infectious Diseases - Economic Evaluation

    May 1, 2020, 00:00

  • PMH35 MENTAL AND BEHAVIORAL DISORDERS DUE TO OPIOID USE IN COLOMBIA: PREVALENCE AND DEMOGRAPHIC CHARACTERISTICS 2009-2018

    May 1, 2020, 00:00

  • PDB14 HYPOTHERMICALLY STORED HUMAN AMNIOTIC MEMBRANE (HSAM) FOR THE MANAGEMENT OF DIABETIC FOOT ULCERS

    May 1, 2020, 00:00

  • PMS56 EPIDEMIOLOGICAL DISEASE BURDEN OF FRACTURE OF SKULL AND FACIAL BONES BASED ON ROUTINELY COLLECTED HEALTH INSURANCE CLAIMS DATA

    May 1, 2020, 00:00

  • PCV58 DEFINING THROMBOEMBOLIC EVENTS USING ADMINISTRATIVE CLAIMS DATA

    May 1, 2020, 00:00

  • PIH4 NUMBER NEEDED TO TREAT (NNT) WITH FENFLURAMINE TO ACHIEVE A CLINICALLY MEANINGFUL REDUCTION IN CONVULSIVE SEIZURE FREQUENCY IN PATIENTS WITH DRAVET SYNDROME: HEALTH ECONOMIC IMPLICATIONS

    May 1, 2020, 00:00

  • PIN5 PREVALENCE OF DRUG RESISTANCE IN NUCLEOSIDE/NUCLEOTIDE ANALOGUE-TREATED EGYPTIAN PATIENTS WITH CHRONIC HEPATITIS B VIRUS

    May 1, 2020, 00:00

  • Musculoskeletal Disorders - Medical Technologies

    May 1, 2020, 00:00

  • PDG70 OPIOID USE IN CHRONIC NON-CANCER PAIN: ANALYSIS USING MEDICAL EXPENDITURE PANEL SURVEY (MEPS) DATABASE

    May 1, 2020, 00:00

  • PIH20 OUTCOME AND ECONOMIC EVALUATION OF NEONATAL SCREENING USING MS/MS FOR INHERITED METABOLIC DISEASES

    May 1, 2020, 00:00

  • PDG50 COMMUNICATION BETWEEN PATIENTS AND HEALTH CARE PROFESSIONALS ABOUT OPIOID MEDICATIONS: A SYSTEMATIC REVIEW

    May 1, 2020, 00:00

  • PDB44 DOES INCLUDING ACUTE PANCREATITIS AS A COMPLICATION HAVE AN IMPACT ON COST-EFFECTIVENESS ANALYSES USING THE IQVIA CORE DIABETES MODEL?

    May 1, 2020, 00:00

  • PMS29 EARLY ECONOMIC EVALUATION DEMONSTRATES THAT ROBOTIC ASSISTED SURGERY IS COST-EFFECTIVE IN PATIENTS UNDERGOING UNICOMPARTMENTAL KNEE ARTHROPLASTY, A UK NATIONAL HEALTH SERVICE PERSPECTIVE

    May 1, 2020, 00:00

  • Infectious Diseases - Epidemiology Public Health

    May 1, 2020, 00:00

  • PMD24 ANALYSIS OF THE COST-EFFECTIVENESS OF THE LEVONORGESTREL RELEASING INTRAUTERINE SYSTEM AS ALTERNATIVE TO HISTERECTOMIES IN PRIVATE HEALTH INSURANCE IN BRAZIL

    May 1, 2020, 00:00

  • Medical Devices - Methodological Statistical Research

    May 1, 2020, 00:00

  • PMD48 ROBOTIC TOTAL HYSTERECTOMY: ASSOCIATION OF SURGICAL INDICATION WITH USE OF ROBOTIC-ASSISTANCE AND RELATED HEALTHCARE RESOURCE UTILIZATION AND COSTS

    May 1, 2020, 00:00

  • Multiple Diseases - Health Policy Regulatory

    May 1, 2020, 00:00

  • Drugs Regulatory

    May 1, 2020, 00:00

  • Alternative Medicine Process of Care

    May 1, 2020, 00:00

  • PMH16 DRUG EXPENDITURE, PRICE, AND UTILIZATION IN THE U.S. MEDICAID PROGRAM: AN EMPIRICAL TREND ANALYSIS FOR SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIS) AND SEROTONIN-NOREPINEPHRINE REUPTAKE INHIBITORS (SNRIS) ANTIDEPRESSANTS FROM 1991 ...

    May 1, 2020, 00:00

  • PIN90 COMPARATIVE QUALITY OF LIFE OUTCOMES OF DOLUTEGRAVIR-BASED OR EFAVIRENZ-BASED ANTIRETOVIRAL TREATMENT IN PREGNANCY FOR LATE PRESENTORS BETWEEN THE 3RD TRIAL-MESTER AND 48 WEEKS POSTPARTUM

    May 1, 2020, 00:00

  • PDB104 OPTIMIZATION OF INSULIN DOSE IN HOSPITALIZED PATIENTS WITH RECURRENT HYPOGLYCEMIA: REAL WORLD EXPERIENCE

    May 1, 2020, 00:00

  • PMU27 ASSESSING RELATIONSHIPS AMONG HOSPITALIZATIONS FOR SPINE-RELATED INFECTIONS, DEMOGRAPHICS, COSTS, AND COMORBIDITY DIAGNOSES IN THE UNITED STATES

    May 1, 2020, 00:00

  • PMH36 THE RELATIONSHIP BETWEEN IRON DEFICIENCY ANAEMIA AND ANTENATAL DEPRESSION AMONG PREGNANT WOMEN

    May 1, 2020, 00:00

  • PMU33 THE IMPACT OF HIGH RISK AND CHRONIC OPOID USE AMONG COMMERCIALLY INSURED ENDOMETRIOSIS PATIENTS ON HEALTHCARE RESOURCE USE AND COSTS IN THE UNITED STATES

    May 1, 2020, 00:00

  • PDB99 BASELINE CHARACTERISTICS OF ENDOMETRIOSIS PATIENTS PARTICIPATING IN A REAL WORLD PROSPECTIVE COHORT STUDY: AN INTERIM ANALYSIS OF THE ELAGOLIX LONGITUDINAL OUTCOMES (LOTUS) STUDY

    May 1, 2020, 00:00

  • PIN72 NON-PRESCRIPTION SALES OF ANTIMICROBIALS FROM COMMUNITY PHARMACIES AND DETERMINANTS OF RESISTANCE IN LAHORE PAKISTAN

    May 1, 2020, 00:00

  • PIN34 COST-UTILITY ANALYSIS OF DIRECT ACTING ANTIVIRALS FOR EARLY-STAGE GENOTYPE 1 HCV PATIENTS IN BRAZIL

    May 1, 2020, 00:00

  • PIH67 EVALUATING THE BURDEN OF ILLNESS OF PEDIATRIC PLATINUM-INDUCED HEARING LOSS: A SYSTEMATIC LITERATURE REVIEW

    May 1, 2020, 00:00

  • PIH45 COST-EFFECTIVENESS OF A CARE PUBLIC PROGRAM FOR PREGNANT WOMEN WHO HAD THEIR DELIVERY IN A THIRD - LEVEL - COMPLEXITY HOSPITAL AT COLOMBIA

    May 1, 2020, 00:00

  • PIH25 PRE-TERM LABOR TRANSPORT: UTILIZATION PATTERNS AND COST AMONG WOMEN IN RURAL AND NON-RURAL AREAS

    May 1, 2020, 00:00

  • PMS62 EPIDEMIOLOGICAL DISEASE BURDEN OF INJURIES TO THE WRIST AND HAND BASED ON ROUTINELY COLLECTED HEALTH INSURANCE CLAIMS DATA

    May 1, 2020, 00:00

  • PDG17 COST-EFFECTIVENESS ANALYSIS OF ARSENIC TRIOXYDE FOR FIRST LINE TREATMENT OF ACUTE PROMYELOCTIC LEUKEMIA

    May 1, 2020, 00:00

  • PDB9 THE COMPARATIVE EFFICACY OF ORAL SEMAGLUTIDE FOR THE TREATMENT OF TYPE 2 DIABETES MELLITUS (T2DM): A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS (NMA)

    May 1, 2020, 00:00

  • PDG13 CURRENT PRESCRIPTION PROFILE OF RIBAVIRIN FOR HEPATITIS C IN BRAZIL AND THE BUDGET IMPACT ANALYSIS ON UPDATED RECOMMENDATIONS FOR ITS USE BETWEEN 2020 AND 2024 IN THE BRAZILIAN PUBLIC HEALTH SYSTEM

    May 1, 2020, 00:00

  • PDB63 MULTIMORBIDTY AND FIVE-YEAR TREND IN DIABETES CARE MANAGEMENT (DCM) AMONG ADULTS WITH DIABETES

    May 1, 2020, 00:00

  • PCV89 ASSESSMENT OF CARE OPPORTUNITY GAPS FOR ATRIAL FIBRILLATION IN NHS ENGLAND

    May 1, 2020, 00:00

  • Mental Health - Health Service Delivery Process of Care

    May 1, 2020, 00:00

  • Cancer - Clinical Outcomes

    May 1, 2020, 00:00

  • PMU50 CHARACTERIZATION AND TRENDS OF MATERNAL MORTALITY IN TWO TERTIARY HOSPITALS IN NIGERIA: WHY DID THEY DIE?

    May 1, 2020, 00:00

  • PDB92 GETTING THE MOST OUT OF LATENT-CLASS ANALYSIS IN MODELING PREFERENCES FOR AN INTERCEPTION TREATMENT IN TYPE 1 DIABETES

    May 1, 2020, 00:00

  • Informing Patient-Centered Care Through Stakeholder Engagement and Highly Stratified Quantitative Benefit–Harm Assessments [Editor's Choice]

    May 1, 2020, 00:00

  • PIN9 ADHERENCE ISSUES AMONG PEOPLE LIVING WITH HIV ON ANTIRETROVIRAL THERAPY AND CONCOMITANT NON-ANTIRETROVIRAL COMEDICATIONS: A SYSTEMATIC REVIEW

    May 1, 2020, 00:00

  • Medical Devices - Epidemiology Public Health

    May 1, 2020, 00:00

  • PIN4 IMPACT OF ADHERENCE ON VIRAL SUPPRESSION IN PATIENTS WITH HIV RECEIVING BICTEGRAVIR OR DOLUTEGRAVIR REGIMENS

    May 1, 2020, 00:00

  • PDB13 ASSOCIATION OF VERAPAMIL THERAPY AND REDUCED HYPOGLYCEMIC EVENTS AMONG MEDICARE PATIENTS WITH NEWLY DIAGNOSED TYPE 1 DIABETES

    May 1, 2020, 00:00

  • PMH17 ECONOMIC BURDEN OF MEDICAID BENEFICIARIES WITH SCHIZOPHRENIA NOT ADHERENT TO ANTIPSYCHOTICS AND WITH SCHIZOPHRENIA RELAPSES

    May 1, 2020, 00:00

  • PCV84 BASELINE CHARACTERISTICS OF HEARTH FAILURE PATIENTS IN A PRIVATE PROVIDER IN CHILE

    May 1, 2020, 00:00

  • PBI23 DEPRESSION AND OBESITY DIFFERENCES AMONG PSORIASIS PATIENTS BY BIOLOGICS TREATMENT

    May 1, 2020, 00:00

  • Alternative Medicine Nutrition - Patient-Centered Research

    May 1, 2020, 00:00

  • PMD46 RETROSPECTIVE ANALYSIS OF OXIDIZED ZIRCONIUM BEARING SURFACE AND MORTALITY IN HIP AND KNEE REPLACEMENT 180-DAY EPISODE CLAIMS

    May 1, 2020, 00:00

  • PMS21 ANNUAL HEALTH INSURANCE TREATMENT COST OF INJURIES TO THE ELBOW AND FOREARM BASED ON ROUTINELY COLLECTED REAL-WORLD FINANCING DATA

    May 1, 2020, 00:00

  • PB3 DISCORDANCE BETWEEN PSYCHIATRISTS AND THEIR PATIENTS ON DISEASE SEVERITY AND TREATMENT OUTCOMES IN SCHIZOPHRENIA

    May 1, 2020, 00:00

  • PMS57 EPIDEMIOLOGIC MODELING TO GUIDE PAYER DECISIONS IN RARE DISEASES: A CASE STUDY OF DUCHENNE MUSCULAR DYSTROPHY IN THE UNITED STATES

    May 1, 2020, 00:00

  • PGI4 RETROSPECTIVE STUDY OF DOSE ESCALATION WITH ADALIMUMAB, INFLIXIMAB, AND VEDOLIZUMAB IN THE TREATMENT OF INFLAMMATORY BOWEL DISEASE

    May 1, 2020, 00:00

  • PMH31 RISK OF FALLS AND FRACTURES ASSOCIATED WITH CONCOMITANT USE OF ACETYLCHOLINESTERASE INHIBITORS AND ATYPICAL ANTIPSYCHOTICS AMONG OLDER ADULTS WITH DEMENTIA

    May 1, 2020, 00:00

  • PCV79 GENDER DISPARITY IN THE INITIATION AND COMPLIANCE FOR STATIN THERAPY IN PATIENTS WITH CORONARY ARTERY DISEASE (CAD)

    May 1, 2020, 00:00

  • PIN56 VACCINE EXPOSURE DURING PREGNANCY AMONG PRIVATELY AND PUBLICLY INSURED WOMEN IN THE UNITED STATES

    May 1, 2020, 00:00

  • PIN89 REGIMEN DURABILITY AMONG HEAVILY TREATMENT-EXPERIENCED (HTE) COMPARED TO NON-HTE TREATMENT-EXPERIENCED HIV PATIENTS IN THE OPERA COHORT

    May 1, 2020, 00:00

  • PIH71 RISK FACTORS ASSOCIATED WITH FALLS AMONG THE ELDERLY IN U.S.: AN ANALYSIS OF MEDICARE CURRENT BENEFICIARY SURVEY DATA

    May 1, 2020, 00:00

  • PMD17 ANALYSIS OF THE COST-EFFECTIVENESS OF ENDOVASCULAR AORTIC REPAIR WITH OFF-THE-SHELF ENDOGRAFTS AS ALTERNATIVE TO CUSTOM-MADE ENDOGRAFTS IN PRIVATE HEALTH INSURANCE IN BRAZIL

    May 1, 2020, 00:00

  • PIH53 PHARMACISTS' INTERVENTIONS IN TRANSITIONS OF CARE: EVALUATING THE FINANCIAL AND CLINICAL IMPLICATIONS FOR LONG-TERM CARE

    May 1, 2020, 00:00

  • Mental Health - Health Technology Assessment

    May 1, 2020, 00:00

  • PDB26 ESTIMATED RENAL AND CARDIOVASCULAR OUTCOMES AND COST OFFSETS IN PATIENTS WITH TYPE 2 DIABETES (T2D) AND DIABETIC NEPHROPATHY (DKD) TREATED WITH CANAGLIFLOZIN

    May 1, 2020, 00:00

  • PMH15 THE CHANGES OF DEPRESSION COSTS AFTER AN INTERNET-DELIVERED COGNITIVE BEHAVIOUR THERAPIES (IDCBT) PRELIMINARY DATA FROM RWD ECONOMIC MODEL

    May 1, 2020, 00:00

  • PIN70 COST OF BLOOD AND BODY FLUID OCCUPATIONAL EXPOSURE MANAGEMENT IN CHINA

    May 1, 2020, 00:00

  • PIN55 ASSOCIATION OF GEOGRAPHIC FACTORS AND SOCIAL DETERMINANTS WITH HERPES ZOSTER VACCINATION

    May 1, 2020, 00:00

  • PMS75 PATIENT- AND PHYSICIAN-IDENTIFIED FACTORS GUIDING TREATMENT CHOICE IN KNEE OSTEOARTHRITIS AND PATIENT PREFERENCE FOR INTRA-ARTICULAR THERAPY

    May 1, 2020, 00:00

  • PDB23 EXLORATION IN HEALTHCARE RESOURCE UTILIZATION (HCRU) STUDY USING EMR DATABASE AND CLAIMS DATA

    May 1, 2020, 00:00

  • PDB24 ANNUAL HEALTH INSURANCE TREATMENT COST OF NON-INSULIN-DEPENDENT DIABETES MELLITUS WITH NEUROLOGICAL COMPLICATIONS BASED ON ROUTINELY COLLECTED FINANCING DATA

    May 1, 2020, 00:00

  • PMS81 PRESCRIPTION DRUG COVERAGE TYPE, OUT-OF-POCKET SPENDING, AND COST-RELATED NONADHERENCE AMONG MEDICARE BENEFICIARIES WITH RHEUMATOID ARTHRITIS

    May 1, 2020, 00:00

  • PDG51 PREVALENCE AND RELATIVE PREDICTIVE VALUE OF DEMOGRAPHIC AND PAIN CHARACTERISTICS FOR OPIOID USE AMONG A NATIONAL SAMPLE OF COMMUNITY-BASED OLDER ADULTS WITH PAIN IN THE UNITED STATES

    May 1, 2020, 00:00

  • Alternative Medicine Information Systems

    May 1, 2020, 00:00

  • Quantifying Downstream Healthcare Utilization in Studies of Genomic Testing

    May 1, 2020, 00:00

  • PDB21 EVALUATION OF THE ONE-YEAR EFFICIENCY OF THE EDUC@DOM TELEMONITORING AND TELE-EDUCATION PROGRAM FOR TYPE 2 DIABETIC PATIENTS

    May 1, 2020, 00:00

  • Methods for Moving the Evaluation of Precision Medicine Into Practice and Policy

    May 1, 2020, 00:00
  • «
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50 (current)
  • »